000 01364 a2200421 4500
005 20250513035018.0
264 0 _c19950918
008 199509s 0 0 eng d
022 _a0886-022X
024 7 _a10.3109/08860229509026248
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDeegan, P M
245 0 0 _aProtection from cisplatin nephrotoxicity by A68828, an atrial natriuretic peptide.
_h[electronic resource]
260 _bRenal failure
_cMar 1995
300 _a117-23 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAtrial Natriuretic Factor
_xadministration & dosage
650 0 4 _aBlood Urea Nitrogen
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aCreatinine
_xblood
650 0 4 _aDisease Models, Animal
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Interactions
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aKidney Function Tests
650 0 4 _aMale
650 0 4 _aNephrosis
_xchemically induced
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
700 1 _aRyan, M P
700 1 _aBasinger, M A
700 1 _aJones, M M
700 1 _aHande, K R
773 0 _tRenal failure
_gvol. 17
_gno. 2
_gp. 117-23
856 4 0 _uhttps://doi.org/10.3109/08860229509026248
_zAvailable from publisher's website
999 _c7644193
_d7644193